TCR2 Therapeutics
ID: 5330812TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.
1
Funding Rounds
$125.0m
Money raised
Recent Funding Rounds
Overview
TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.
- Website:
- Headquarters: Cambridge, Massachusetts
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Sh*** To******* | - | - | - |
| Ga*** Me**** | - | - | |
| An**** Al*** | - | - | - |
| An***** Ga***** | - | - |
Industries
TCR2 Therapeutics is active in the following industries: